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ABSTRACT Enterococcus faecium has recently emerged as an important multiresistant nosocomial pathogen. Defining population
structure in this species is required to provide insight into the existence, distribution, and dynamics of specific multiresistant or
pathogenic lineages in particular environments, like the hospital. Here, we probe the population structure of E. faecium using
Bayesian-based population genetic modeling implemented in Bayesian Analysis of Population Structure (BAPS) software. The
analysis involved 1,720 isolates belonging to 519 sequence types (STs) (491 for E. faecium and 28 for Enterococcus faecalis).
E. faecium isolates grouped into 13 BAPS (sub)groups, but the large majority (80%) of nosocomial isolates clustered in two sub-
groups (2-1 and 3-3). Phylogenetic and eBURST analysis of BAPS groups 2 and 3 confirmed the existence of three separate hospi-
tal lineages (17, 18, and 78), highlighting different evolutionary trajectories for BAPS 2-1 (lineage 78) and 3-3 (lineage 17 and
lineage 18) isolates. Phylogenomic analysis of 29 E. faecium isolates showed agreement between BAPS assignment of STs and
their relative positions in the phylogenetic tree. Odds ratio calculation confirmed the significant association between hospital
isolates with BAPS 3-3 and lineages 17, 18, and 78. Admixture analysis showed a scarce number of recombination events between
the different BAPS groups. For the E. faecium hospital population, we propose an evolutionary model in which strains with a
high propensity to colonize and infect hospitalized patients arise through horizontal gene transfer. Once adapted to the distinct
hospital niche, this subpopulation becomes isolated, and recombination with other populations declines.
IMPORTANCE Multiresistant Enterococcus faecium has become one of the most important nosocomial pathogens, causing in-
creasing numbers of nosocomial infections worldwide. Here, we used Bayesian population genetic analysis to identify groups of
related E. faecium strains and show a significant association of hospital and farm animal isolates to different genetic groups. We
also found that hospital isolates could be divided into three lineages originating from sequence types (STs) 17, 18, and 78. We
propose that, driven by the selective pressure in hospitals, the three hospital lineages have arisen through horizontal gene trans-
fer, but once adapted to the distinct pathogenic niche, this population has become isolated and recombination with other popu-
lations declines. Elucidation of the population structure is a prerequisite for effective control of multiresistant E. faecium since it
provides insight into the processes that have led to the progressive change of E. faecium from an innocent commensal to a multi-
resistant hospital-adapted pathogen.
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In the past two decades, Enterococcus faecium has become recog-nized as an important nosocomial pathogen. Up to the 1980s,
the large majority of enterococcal hospital-associated infections
(HAI) were caused by Enterococcus faecalis, but since the begin-
ning of the 1990s, the proportion of HAI caused by E. faecium has
increased and has now almost reached parity with that of E. faeca-
lis (1). One proposed reason for this changing epidemiology is
that, in comparison with E. faecalis, E. faecium shows relatively
high rates of resistance against important antibiotics, including
ampicillin and vancomycin. In addition, studies of the population
biology of E. faecium using multilocus sequence typing (MLST)
data have revealed the existence of a distinct genetic subpopula-
tion associated with nosocomial epidemics. This subpopulation
has been designated lineage C1 (2) and was later renamed clonal
complex 17 (CC17) on the basis of eBURST (3) analysis of MLST
data (4, 5).
CC17 has been recognized as a successful hospital-associated
E. faecium (HA E. faecium) clonal complex, exhibiting high-level
vancomycin, ampicillin, and quinolone resistance, although in
most European countries CC17 remained primarily vancomycin
susceptible (4, 6, 7, 8, 9, 10, 11, 12, 13). However, in addition to
this distinct resistance profile, genome-wide analyses have shown
that HA E. faecium strains have a genetic repertoire distinct from
that of E. faecium strains that asymptomatically colonize the gas-
trointestinal (GI) tract of humans and animals in the community
(14, 15). This distinct genetic repertoire includes cell surface pro-
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teins, of which the enterococcal surface protein, Esp, is a known
virulence determinant (8, 10, 16, 17, 18, 19, 20, 21, 22, 23);
genomic islands tentatively encoding novel metabolic pathways
(24); and insertion sequence elements (14). It is now considered
that these determinants may be adaptive elements that have im-
proved the relative fitness of this HA E. faecium subpopulation in
the hospital environment (5, 9, 25, 26).
Despite the clear importance of CC17 as the main genetic sub-
population, including hospital isolates, its precise phylogenetic
status remains uncertain. Analyses of the population structure of
E. faecium indicate that this species undergoes a high rate of ho-
mologous recombination (4, 27). High recombination rates can
lead to error in phylogenetic analyses. This is especially true if only
a small portion of the genome is interrogated. In the case of the
eBURST approach used to define CC17, a consequence of large
amounts of recombination is the spurious grouping of diverse and
distinct lineages into a single clonal complex. It has previously
been suggested (28) that phylogenetic reconstructions of E. fae-
cium are vulnerable to such errors. Analyses using alternative
methods to eBURST suggest this may be the case, with the con-
stituent lineages of CC17 (sequence types [STs] 17, 18, 78, and 80)
representing distinct genetic lineages of which the relationships
between cannot be confidently assigned (5, 26, 27). Together with
the observation that whole genome sequences of two CC17 iso-
lates (E1162 [ST17] and U0317 [ST78]) differ substantially in
gene content (15), this strongly indicates that HA E. faeciummay
not have evolved from a single founder (i.e., ST17) and that, con-
sequently, CC17 as presently identified may not exist but is an
artifact of the assumptions embedded within the eBURST algo-
rithm.
An alternative approach to eBURST is an analysis of genetic
population structure, with the power to combine the identifica-
tion of deep branching lineages and recombination between them.
This can be done using Bayesian Analysis of Population Structure
(BAPS) software (29, 30, 31). Unlike approaches such as eBURST
(3), BAPS does not attempt to retrieve phylogenetic information
or implement a phylogenetic model of clustering but rather uses a
statistical genetic model to partitionmolecular variation based on
both clonal ancestry and recombination patterns as identified
fromDNA sequence data. This approach has recently been used to
probe genetic population structure in Streptococcus pneumoniae
(32), Escherichia coli (33), Campylobacter coli, Campylobacter je-
juni (34, 35), andNeisseria spp. (36) and has been shown to be able
to detect structure even in highly recombinogenic populations.
Here, we used BAPS to identify groups of related E. faecium strains
and show a significant association of hospital and farm animal
isolates to different BAPS groups. We suggest that hospital-
associated lineages contained in different BAPS groups have, how-
ever, acquired similar adaptive elements.
RESULTS
BAPS-based genetic structure in the E. faecium population.The
data set used for our analysis consisted of 519 distinct STs, of
which 491 were found among 1,720 E. faecium isolates and the
remaining 28 STs in 29 E. faecalis isolates. The eBURST analysis
based on the 491 E. faecium STs yielded 19 eBURST groups and
101 singletons (STs not part of an eBURST group or clonal com-
plex) (Fig. 1). The largest eBURST group included 329 (67%) of
the STs and 1,459 (85%) of the isolates, indicating that eBURST
might be unreliable in estimating relatedness in this large straggly
E. faecium group.
To gain an alternative perspective on E. faecium population
structure, we used a Bayesian population geneticmodel to identify
clusters characterized by different allele frequencies based onmul-
tilocus DNA sequences (31). The 519 STs were partitioned into 7
groups, of which groups 1 to 6 included the E. faecium isolates,
while BAPS group 7 was entirely composed of E. faecalis isolates
(Table 1). BAPS groups 2 and 3 represented the majority of the
sample, containing 227 (44%) and 190 (40%) of the STs and 829
(47%) and 784 (45%) of the isolates, respectively (Table 1). It is
known that in Bayesian model-based analysis, fine distinctions
between closely related clusters can be obscured by the presence of
relatively distant clusters in the data, which produce a large
amount of signal and consequently render smaller signals of dif-
ference insignificant (see, e.g., the discussion in the work of
Marttinen et al. [37]). As a result, BAPS groups 2 and 3 were each
individually analyzed using BAPS. This nested analysis strategy
was implemented to provide greater resolution of population
structure in these groups. The results showed four subgroups of
BAPS group 2 (BAPS 2-1 to 2-4) and five subgroups of BAPS
group 3 (BAPS 3-1 to 3-5) (Table 1). The nested analysis thus
finally subdivided the E. faecium population into 13 distinct sub-
populations and one E. faecalis BAPS group 7. Given the smaller
sizes of the subgroups emerging in the second stage of clustering
compared to the initial analysis, it is not feasible to split these
subgroups even further by successively repeating the clustering
procedure, as there will not be enough variation in the data to
reliably infer the underlying groups.
Distribution of E. faecium isolates among BAPS
(sub)groups. Two BAPS groups (2-1, 3-3) contained themajority
(80%) of isolates from hospitalized patients (Table 1). However,
BAPS 2-1 also contained a large number of animal-related isolates,
in contrast with BAPS 3-3.
To assess significance of associations between BAPS groups
and isolate sources, odds ratios (ORs) were calculated. This re-
vealed a significant association of hospital and farm animal iso-
lates to different BAPS groups. Strikingly, BAPS group 3-3 was
positively associated with isolates retrieved from hospitalized pa-
tients, whereas hospital isolates were negatively associated with
BAPS groups 1, 2-1, 2-3, 3-2, and 3-4. In turn, isolates from farm
animals were significantly associated with BAPS groups 2-1, 2-3,
2-4, 3-2, and 5 and negatively associated with BAPS group 3-3 (see
Table 2). To examine whether sampling bias could influence re-
sults by inflating the numbers of individual STs, ORs were calcu-
lated based on a single example of each ST. The results confirmed
positive association of BAPS 3-3 with hospitalized patients and
BAPS 2-1 and 2-4 with farm animals and negative association of
BAPS 2-1 and 3-2 with hospitalized patients and BAPS 3-3 with
farm animals (see Table S2 in the supplemental material).
STs 17, 18, and 78 are important nodes in the previously de-
scribed CC17, a globally distributed clonal complex identified by
eBURST analysis (Fig. 1). To correct for erroneous linkage intro-
duced by eBURST in organisms like E. faecium, which have a high
recombination-to-mutation ratio (28), we have divided CC17
into lineages arising from each of the subfounder STs (shown in
Fig. 1), namely, STs 17, 18, and 78. Two of these (STs 17 and 18,
together with descendant STs) are included in BAPS 3-3, which
has the strongest and most significant association with hospital-
associated isolates among all these groups. eBURST analysis of STs
Willems et al.
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belonging to the two largest BAPS groups, BAPS 2-1 and BAPS
3-3, revealed coclustering of STs representing the majority of
hospital-associatedE. faecium isolates (881; 74%) into threemajor
lineages: lineage 78 (364 isolates; 42 STs) in BAPS 2-1 and lineage
17 (328 isolates; 35 STs) and lineage 18 (189 isolates; 26 ST) in
BAPS 3-3 (see Fig. S1 and S2 in the supplemental material). ORs
FIG 1 eBURST-based population snapshot of E. faecium based on 519 STs representing 1,749 isolates contained in the online E. faecium MLST database
(http://efaecium.mlst.net). STs belonging to lineages 17, 18, and 78 are color coded in blue, red, and yellow, respectively.
TABLE 1 Distribution of STs and isolates among BAPS subpopulations
BAPS
group
BAPS
subgroup
No.
of STs
No. of E. faecium isolates from:
No.
of E. faecalis
isolates
Total
no. of isolates
Hospital
patients
Nonhospital
persons Pets Pigs Poultry Calves Othera Unknown
1 53 36 12 0 10 0 0 11 14 0 83
2 1 148 403 18 71 34 97 0 20 30 0 673
2 1 1 0 0 0 0 0 0 0 0 1
3 63 74 9 7 7 3 17 6 5 0 128
4 15 15 0 1 1 3 0 5 2 0 27
3 1 44 53 6 7 8 1 0 8 3 0 86
2 17 13 9 4 14 1 0 1 6 0 48
3 104 547 10 8 6 12 3 8 10 0 604
4 4 2 4 0 1 0 0 0 0 0 7
5 21 21 1 9 0 4 0 2 2 0 39
4 9 6 1 0 0 0 0 1 1 0 9
5 9 5 0 0 2 2 0 0 1 0 10
6 3 4 0 0 0 0 0 0 1 0 5
7 28 0 0 0 0 0 0 0 0 29 29
Total 519 1,180 70 107 83 123 20 62 75 29 1,749
a Includes animal food products (n 29), other animal isolates, or isolates from nonspecified animals (n 8) and environmental isolates (n 25).
Enterococcus faecium Population Genetics
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confirmed a significant association of lineages 17, 18, and 78 with
hospital isolates and a significant negative associationwith isolates
from farm animals and meat products (Table 2; see also Table S2
in the supplemental material).
Comparison of BAPS-based grouping and whole-genome
phylogenomics. BAPS grouping is based on the concatenated se-
quences of the seven MLST housekeeping genes, which consist of
3,463 bp of DNA sequence. To examine whether the groupings we
find are concordant with those based on a larger fraction of the
genome, we constructed a phylogenetic tree based on 299 ortholo-
gous proteins representing 64,555 amino acids contained in the 29
E. faecium strains for which a genome sequence is available. The
phylogenomics analysis showed agreement between BAPS assign-
ment of STs and their relative position in the phylogenetic tree
(Fig. 2). Isolates belonging to BAPS 1 clustered far from BAPS 2
and 3 isolates, and distinct groups of isolates corresponding to the
BAPS 2-1 and 3-3 subgroups were observed. This suggests that the
groupings identified by BAPS analysis of MLST loci reflect a deep
phylogenetic structure that is also apparent in larger samples of
loci and hints toward functional differences between the sub-
groups. The phylogenomic tree suggests one monophyletic group
consisting of isolates belonging to the three hospital-adapted lin-
eages 17, 18, and 78. However, despite the increased amounts of
data available for the construction of the phylogenomic tree in Fig.
2, it must be treated with caution, because sample size and the
sampling frame for Fig. 2 is markedly different from that available
for MLST data. A neighbor-joining tree based on concatenated
alignments of MLST gene sequences contained in the two largest
BAPS (sub)groups, BAPS 2 and BAPS 3, clearly indicate phyloge-
netic diversity between BAPS 2 (lineage 78) and BAPS 3 (lineages
17 and 18) (see Fig. S3 in the supplemental material).
Evolution of the hospital-associated E. faecium population.
The fact that animals, specifically poultry and pet animals, are
significantly associated with BAPS 2-1 and hospital-associated
isolates with BAPS 3-3 suggests a distinction between these two
habitats. However, approximately a third (31%) of isolates from
hospitalized patients, including the major hospital lineage 78, co-
cluster with isolates from animal sources in BAPS 2-1 (Table 1).
We interpret this as evidence that this subset of hospital-
associated isolates has emerged separately fromhospital isolates in
BAPS 3-3 and has a distinct evolutionary history.
Further examination of the constituent lineages of CC17 (i.e.,
lineages 17 and 18 in BAPS groups 3-3 and lineage 78 in 2-1)
suggests that other important clinical features, such as ampicillin
resistance and the presence of the esp virulence factor, which is
implicated in biofilm formation, urinary tract infections, and en-
docarditis (17, 22, 23), are common. The esp gene is recorded as
present in 73%and 72%of hospital isolates in lineage 17 (n 248)
TABLE 2 Associations between E. faecium isolates from hospitalized patients and farm animals with BAPS groups and lineages
Source BAPS group Lineage No. of isolates from source Total no. of isolatesa ORsc 95% CI
Hospitalized patients 1 36 69 0.41 0.254–0.669
2-1 allSTs 403 643 0.49 0.391–0.605
2-1 78 364 453 1.89 1.45–2.449
2-2 1 1 ND
2-3 74 123 0.57 0.389–0.829
2-4 15 25 0.59 0.261–1.314
3-1 53 83 0.68 0.43–1.082
3-2 13 42 0.17 0.086– 0.325
3-3 allSTs 547 594 7.69 5.567–10.61
3-3 17 329 342 13.44 7.633–23.67
3-3 18 190 196 14.69 6.465–33.341
3-4 2 7 0.16 0.03–0.808
3-5 21 37 0.51 0.263–0.983
4 6 8 1.18 0.238–5.883
5 5 9 0.49 0.131–1.834
6 4 4 ND
Farm animalsb 1 14 69 1.54 0.743–2.477
2-1 allSTs 144 643 2.14 1.64–2.795
2-1 78 4 453 0.03 0.012–0.087
2-2 0 1 ND
2-3 30 123 1.79 1.156–2.756
2-4 9 25 3.03 1.322–6.921
3-1 13 83 0.98 0.531–1.789
3-2 16 42 3.38 1.786–6.39
3-3 allSTs 26 594 0.16 0.103–0.239
3-3 17 2 342 0.02 0.006– 0.095
3-3 18 2 196 0.05 0.012–0.19
3-4 1 7 0.88 0.105–7.301
3-5 6 37 1.02 0.42–2.463
4 0 8 ND
5 4 9 4.25 1.135–15.945
6 0 4 ND
a E. faecium isolates in the source categories of hospitalized patients, farm animals, and other sources. Isolates from unknown sources were not included. In total, 1,645 isolates
were included in the analysis.
b Pigs, poultry, veal calves, meat, and milk products.
c ORs indicate significance of association between E. faecium source categories and BAPS (sub)group and lineage. ND, not done.
Willems et al.
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and 78 (n  363) isolates, respectively. In contrast, only 31% of
lineage 18 isolates (n  154) are recorded as having this gene
present, which compares with 18% in the remainder of the popu-
lation for which esp presence or absence was recorded (n  404
isolates). The other feature that is present at increased frequency
in all three hospital-associated lineages is ampicillin resistance,
which is practically ubiquitous among lineage 17, 18, and 78 hos-
pital isolates (more than 98% of isolates belonging to one of these
three lineages are resistant) but, in contrast, is less frequent among
the rest of the data set (35%). In a previous publication, using a
mixed whole-genome array, we identified additional genes that
were enriched among hospital isolates (14). Five genes that ranked
highest as genes predictive for hospital isolates in a character evo-
lution analysis in this previous study were also enriched among
lineage 17, 18, and 78 hospital isolates (63 to 100%), while being
relatively rare among the remainder of the E. faecium population
(10 to 30%) (see Table S3 in the supplemental material). Also,
SgrA, a nidogen-binding LPXTG surface adhesion implicated in
biofilm formation, and EcbA, a collagen binding MSCRAMM
(21), are significantly enriched among isolates belonging to the
three hospital lineages as well as a genomic island tentatively en-
coding a metabolic pathway involved in carbohydrate transport
and metabolism (24) (see Table S3). We propose that the enrich-
ment of esp in two of the hospital-adapted lineages, which include
BAPS groups 3-3 and 2-1, is a result of separate acquisition leading
to selection in hospitals and that the same applies to ampicillin
resistance and the seven additional genes and the genomic island.
Admixtureanalysis andgeneflownetworks inE. faeciumand
between E. faecium and E. faecalis. The BAPS program was used
to identify cases of admixture in which genotypes (STs) contain
sequences characteristic of more than one subpopulation. For
BAPS groups 2 and 3, the vast majority of genotypes have se-
FIG 2 Minimum evolution tree based on the concatenated alignments of 299 orthologous proteins conserved in draft genome sequences of 29 E. faecium
isolates. Bootstrap values are indicated and are based on 1,000 permutations. Strain codes are indicated as well as ST, BAPS group, and lineage based on their ST.
Accession numbers: E. faecium 1231408, GenBank NZ_ACBB00000000; E. faecium 1231501, GenBank NZ_ACAY00000000; E. faecium TX0133A, GenBank
NZ_AECH00000000; E. faecium TX0082, GenBank NZ_AEBU00000000; E. faecium C68, GenBank NZ_ACJQ00000000; E. faecium 1231410, GenBank
NZ_ACBA00000000; E. faecium 1230933, GenBank NZ_ACAS00000000; E. faecium E4453, GenBank AEDZ00000000; E. faecium 1231502, GenBank NZ_A-
CAX00000000; E. faecium E4452, GenBank AEOU00000000; E. faecium D344, GenBank NZ_ACZZ00000000; E. faecium TC6, GenBank NZ_ACOB00000000;
E. faecium Com15, GenBank NZ_ACBD00000000; E. faecium 1141733, GenBank NZ_ACAZ00000000; E. faecium PC4.1, GenBank NZ_ADMM00000000;
E. faecium Com12, GenBank NZ_ACBC00000000; E. faecium TX1330, GenBank NZ_ACHL00000000; E. faecium E980, GenBank ABQA00000000; E. faecium
E1039, GenBank ACOS00000000; E. faecium E1071, GenBank ABQI00000000; E. faecium E1162, GenBank ABQJ00000000; E. faecium E1636, GenBank
ABRY00000000; E. faecium E1679, GenBank ABSC00000000; E. faecium U0317, GenBank ABSW00000000; E. faecium DO, GenBank NZ_ACIY00000000.1;
E. faecium TX133a01, GenBank NZ_AECJ00000000.1; E. faecium TX133a04, GenBank NZ_AEBC00000000.1; E. faecium TX133B, GenBank
NZ_AECI00000000.1; E. faecium TX133C, GenBank NZ_AEBG00000000.1. Strains 1231408, PC4.1, and Com15 lack a BAPS (sub)group designation because
STs extracted from the genome sequences of these strains were not assigned yet at the time the BAPS analysis was performed. To improve resolution of the upper
part of the tree, the top 22 non-BAPS 1 strains were separately clustered using the minimum evolution method.
Enterococcus faecium Population Genetics
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quence signatures of only one BAPS group, which is indicative of
fairly restricted recombination between these groups (Fig. 3A and
B; see also Fig. S4 in the supplemental material). Nevertheless, the
gene flow diagram shows admixture between BAPS 2 and BAPS 3,
with almost 5% of the sequences in BAPS 3 having characteristics
of BAPS 2, while for genotypes in BAPS 2, only 0.25% of the
sequences have characteristics of BAPS 3. In BAPS groups 1, 4, and
6, at least 94% of the sequences are characteristic of that group,
pointing toward restricted recombination also in these BAPS
groups (significance of admixture was determined for each ST
using the threshold of P values of 0.05). In contrast, BAPS 5
shows more mosaicism, with substantial gene flow from BAPS 1,
2, 3, and 6.
Although levels of admixture seem to be relatively low in BAPS
groups 2 and 3, it is apparent from Fig. 3 that some mosaic geno-
types do exist. More STs in BAPS 3 (15%) showed admixture than
in BAPS 2 (6%). Within BAPS 3, admixture was most explicit in
subgroups 3-2 and 3-4, which were entirely composed of mosaics
(see Fig. S4 in the supplemental material). In BAPS 3-2, the most
commondonor is BAPS 2 (49%of STs), while in BAPS 3 to 4, 67%
of STs contain sequences characteristic of BAPS 2, and the remain-
ing 33% of BAPS 1. As such, BAPS 3-2 and 3-4 represent clear
examples of populations identified by the BAPS software from
traces left by recombination events (31). This suggests that the
extent of recombination is unevenly distributed among the lin-
eages of E. faecium, similar to the earlier reported findings for the
Pneumococcus and Meningococcus based on comparable data and
analysis (32, 36). However, given the relatively small number of
isolates found in these populations, the potential importance of
this finding for the E. faecium population biology remains open
for further examination. Relatively high levels of admixture in
BAPS 3 were found in STs from nonhospitalized persons (30% of
STs) and pigs (40% of STs), while among STs from hospital iso-
lates in BAPS 3, most notably in BAPS 3-3, the number of signif-
icantly admixed STs was low (3% of STs) (see Table S4 in the
supplemental material). There was no significant association (es-
timated by ORs and confidence intervals [CIs] as previously de-
scribed) between ampicillin resistance or the presence of esp and
STs with significant admixture. Detailed analysis of admixture in
MLST gene sequences by characterizing molecular variation at all
sites indicates that traces of admixture are present in allMLST loci,
and thus these results are not the result of anomalous ancestry at a
single gene (data not shown).
Mixed cultures can produce erroneous evidence for recom-
bination between named species. Three BAPS groups contain
divergent alleles, apparently reflecting recombination between
FIG 3 Admixture analysis in the Enterococcus population. (Top) Admixture analysis of 519 distinct enterococcal genotypes. Each column represents a single
MLST and is colored according to the proportion of genetic variation assigned to each BAPS group. The final cluster assignment is shown by the color
underneath. (Bottom)Gene flownetwork identified in the Enterococcus population. Arrows indicate the average fraction of sequence variation obtained from the
source cluster by clones assigned to the target cluster. Circular loops indicate the fraction of variation estimated as not arising from outside the BAPS group.
Willems et al.
6 ® mbio.asm.org July/August 2012 Volume 3 Issue 4 e00151-12
 
m
bio.asm
.org
 o
n
 Septem
ber 21, 2016 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
named species. BAPS 4, involving gdh and gyd, and BAPS 6, in-
volving atpA, gdh, gyd, and adk, contain a mix of E. faecalis and
E. faecium alleles, while BAPS 5 contains mainly individual diver-
gent atpA E. faecalis-like alleles and a single ST harboring an allele
typical of Enterococcus hirae as identified by BLAST. The small
number of isolates (24; and 21 STs) contained in these BAPS
groups represent isolates fromhospitalized patients (15), nonhos-
pitalized persons (1), farm animals (4), the environment (2), and
unknown origin (2), from 9 countries (Brazil, China, Finland,
France, Netherlands, Portugal, Spain, Taiwan, and United King-
dom).
Such mosaic STs can be generated either by genuine recombi-
nation between named species or by mixed cultures that yield
sequences from both species present. Repeated culture and se-
quencing of eight BAPS 4 isolates with ST105, ST164, ST325,
ST326, ST331, ST332, ST353, and ST357 and three BAPS 6 isolates
with ST419 revealed allelic profiles that were not identical to the
ones reported for these STs in the MLST database. The “new”
allelic profiles for these STs did no longer include typical E. faecalis
alleles, indicating that these STs in fact do not represent mosaic
STs but most probably were the result of mixed cultures. This
means that these STs most probably do not exist. BAPS 5 isolates
with ST366, ST367, ST369, ST394, ST405, ST428, ST436, ST444,
and ST484 as well as BAPS 6 isolates with ST335 and ST362 were
not available for testing, and we propose that the evidence of re-
combination in these STs should be assumed to be an experimen-
tal artifact, as in the case of BAPS 4 and BAPS 6. These results
indicate that the utmost care must be taken when inferring rare
recombination events over large distances.
DISCUSSION
Multiresistant E. faecium has become one of the most important
nosocomial pathogens. Emergence of multiresistant E. faecium
strains is a problem at multiple levels. From a clinical perspective,
they are among the most resistant opportunistic nosocomial
pathogens, with an increasing impact on patients receiving health
care. Moreover, in terms of the emergence of resistance and their
considerable capacity of genetic exchange linked to high recom-
bination rates, E. faecium is the perfect hub for resistance genes
facilitating horizontal gene transfer among bacterial species. A
high relative recombination rate means that eBURST, a popular
cluster algorithm for MLST data, cannot reliably delineate the
patterns of recent evolutionary descent of E. faecium (28). Here,
we have used BAPS software to probe the genetic structure and
evolution of E. faecium. The BAPS-based partition revealed a non-
random distribution of animal isolates among BAPS populations
and a significant association of isolates derived from hospitalized
patients with specific groups that are negatively associated with
isolates from farm animals. This is consistent with previous find-
ings that demonstrated host specificity and distinct clustering of
animal and human community isolates from clinical isolates
based on clustering of amplified fragment length polymorphism
(AFLP) profiles (38) and on comparative genomic hybridizations
using an E. faecium mixed whole-genome array (14). The obser-
vation is also consistent with previous analysis ofMLSTdata at the
level of individual STs, confirming that the majority of hospital
outbreak and infectious isolates are genotypically distinct from
the majority of human commensal and animal isolates. Conse-
quently, antibiotic-resistant clones originating from farm animals
appear not to be responsible for the emergence of antibiotic-
resistant E. faecium in hospitalized patients (27). However, the
previous finding of indistinguishable vancomycin resistance
transposons in pigs, nonhospitalized persons, and hospitalized
patients indicates that while animal-derived E. faecium clones
containing antibiotic resistance genes may not be responsible for
infections in hospitalized patients, the resistance genes themselves
may be laterally transferred from animal isolates to human clinical
isolates (16).
Three E. faecium STs, ST17, ST18, and ST78, and STs repre-
senting their recent evolutionary descendants are significantly en-
riched among clinical and outbreak-associated isolates of hospi-
talized patients and represented major subgroup founders of the
previously designated CC17, a presumed hospital-derived sub-
population of E. faecium that has spread globally (4, 7, 8, 39, 40).
BAPS, however, resolved CC17 into two different subgroups,
BAPS 2-1 and BAPS 3-3, with ST78 and descendants belonging to
BAPS 2-1, separated from ST17 and ST18, both belonging to
BAPS 3-3. This is consistent with the suggestion that CC17, as a
monophyletic entity containing themajority of hospital isolates, is
probably an artifact of documented problems with eBURST-
based clustering (28), which have led to erroneous linkage of the
three main hospital lineages (lineages 17, 18, and 78) into CC17.
Two recent comparative genomic studies of E. faecium, includ-
ing 8 to 21 isolates, for which draft whole genome sequences were
available, identified a deep phylogenetic split between two E. fae-
cium clades that were designated clade A and clade B (using the
terminology of Palmer and coworkers [41]) or commensal (CA)
and hospital (HA) clades (using the terminology of Galloway-
Peña and coworkers [42]). We found, using essentially the same
genome sequence data, the same ancient split with isolates belong-
ing to BAPS 1 clustering in a separate clade (B or CA), while those
belonging to all the other BAPS groups clustered in clade A (or
HA). Also, the topology of the phylogenetic tree described in a
recent publication by Lam and coworkers (43) that includes the
first complete genome sequence of an E. faecium strain is highly
similar to the subtree we show in Fig. 2, representing only the
upper 22 non-BAPS 1 strains. Our study, however, revealed that
BAPS 1 isolates do not solely represent community isolates but
that 43% of BAPS 1 isolates also represent isolates recovered from
hospitalized patients, indicating that clade B or the CA clade is not
representative only for community isolates. Similarly, isolates be-
longing to the other BAPS groups do not only include hospital
isolates but also represent the vast majority of farm and pet ani-
mals, which indicates that clade A or the HA clade is not exclu-
sively representative for hospital isolates. More importantly, our
BAPS analysis demonstrated that hospital isolates belong to dif-
ferent evolutionary clusters and thus do not share a recent com-
mon ancestor—recent in this sense meaning since the establish-
ment of modern hospitals and the dawn of the antibiotic era. The
diversification of hospital-associated clusters is something that
has happened relatively recently compared to the deep split be-
tween the two clades mentioned above, because appearance of
large-scale hospitals and the use of antibiotics represent very re-
cent events in evolutionary time. Using whole genome sequence
information of 21 human E. faecium isolates, the split between the
CA clade and HA clade was calculated to have occurred between
300,000 and 3million years ago, while strains in theHA cladewere
estimated to have diverged from each other ~100,000 to
300,000 years ago (42). However, with a poor sampling of strains
(a relatively limited number of strains, which were all human de-
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rived) and a relatively simple analysis taking into account muta-
tion rates of Escherichia coli and Bacillus anthracis, it is nearly
impossible to say anything serious about divergence times for a
very recombinogenic organism like E. faecium. Onewould need to
carefully purge the data and be very certain that almost all varia-
tion that is left is due to mutation. Even then it is not easy to
calibrate the clock and estimate divergence times, since mutation
and recombination frequency may differ between bacterial popu-
lations that reside under different selective pressure.
The finding that ST78 is part of a different BAPS group (BAPS
2-1) than ST17 and ST18 (BAPS 3-3) suggests a distinct evolution-
ary history for hospital lineage 78. This is supported by the
neighbor-joining tree based on concatenated MLST gene se-
quences of BAPS 2 and BAPS 3 (sub)groups (see Fig. S3), as well as
a ClonalFrame analysis of the population presented in reference 5.
While STs 17 and 18 (and descendant STs) are grouped in BAPS
3-3, which is significantly associated with hospital-derived iso-
lates, lineage 78 coclusters with themajority of animal, specifically
poultry, isolates in BAPS 2-1. Based on this observation, we hy-
pothesize that the genetic evolution of hospital clones belonging
to lineage 78 possibly involved animals (poultry or pet animals) as
the ancestral origin since poultry isolates constitute the largest
proportion of animal isolates in BAPS 2-1 and because lineage 78
was also significantly associated with STs from pet animals (data
not shown). In fact, it is not implausible to speculate that the
hospital-associated lineages 17, 18, and 78 all arose by connection
to animals. BAPS 3-2, which is also significantly associated with
animals and evolutionarily closely related to BAPS 3-3, that in-
cludes lineage 17 and lineage 18, contains a relatively high propor-
tion of pig isolates (29% of all isolates in this BAPS group).
The observed coclustering, based on gene content, of E. fae-
cium hospital isolates belonging to lineages 17, 18, and 78 (14)
indicates cumulative acquisition of adaptive elements, such as am-
picillin resistance and the esp virulence gene, by specific genotypes
multiple times during the evolution of E. faecium. Future whole-
genome-based phylogenomics analysis will provide more insights
into the evolutionary history and gene content of isolates belong-
ing to the lineages 17, 18, and 78 and the order with which partic-
ular adaptive loci and phenotypes, such as ampicillin resistance
and esp, were acquired. If true, this suggests that the continuous
rise of nosocomial E. faecium infections is not the result of clonal
expansion of a single successful clone or lineage that emerged in
hospitals 20 years ago but of consecutive waves of different clones/
lineages that have evolved and were subsequently selected in hos-
pitals.
Despite high estimated levels of recombination in E. faecium
(4, 27), admixture and gene flow analysis indicated limited
amounts of admixture between BAPS groups. Of the three largest
BAPS groups (1, 2, 3), E. faecium isolates in BAPS 3 show higher
levels of admixture, with mosaic genotypes concentrated among
isolates fromnonhospitalized persons andpigs (see Table S4 in the
supplemental material). This may reflect an increased ability to
accept foreign DNA or greater ecological opportunity for recom-
bination. It remains to be investigated which mechanisms are re-
sponsible for the observed higher admixture level in BAPS 3. Re-
cently, Manson and coworkers described chromosome-
chromosome transfer of resistance and virulence genes as well as
MLSTmarkers between E. faecalis strains (44). This indicates that
plasmid-mediated mobilization of chromosomal DNA contrib-
utes toMLST diversity in E. faecalis (44), and it is not unlikely that
similar mechanisms may exist in E. faecium. Hospital isolates, ei-
ther contained in BAPS 2 or BAPS 3, display only low levels of
admixture, which may point to genetic isolation of hospital-
derived E. faecium.
In conclusion, BAPS analysis provided new insights into the
population structure of E. faecium, suggesting that CC17 should
be divided into constituent groups descending from STs 17, 18,
and 78. This analysis, as well as previous typing data, indicates a
certain level of host specificity and suggests ecological isolation for
some E. faecium populations. For the hospital population, we pro-
pose a model of enterococcal evolution in which strains with high
invasive potential arise through horizontal gene transfer, but once
adapted to the distinct pathogenic niche the population becomes
isolated and recombination with other populations declines. This
corroborates previous observations that hospital isolates carry a
number of resistance and putative virulence genes not found
among community/animal isolates. Analysis of the composition
of the E. faecium hospital population over time from literature
references suggests successive waves of successful E. faecium STs
from lineages 17 and 18 in the years 1990 to 2004 (8) to lineage 78
from 2005 (7, 39, 45, 46, 47, 48, 49). The recently successful hos-
pital lineage 78 (BAPS 2-1) seems to have an evolutionary history
which is distinct from lineages 17 and 18 (BAPS 3-3) that domi-
nated in the 1990s andmay have evolved from farm animals, most
probably poultry, or pet animals. The emergence of E. faecium as a
leading nosocomial pathogen has paralleled the emergence of
these three genetically distinct hospital lineages with increased
potential of hospital spread. These lineages are enriched in proven
and putative virulence genes, like the esp gene and other genes
encoding surface proteins and surface appendages like pili (20)
that have enabled specific hospital-adapted clones belonging to
these lineages to colonize and invade hospitalized patients. The
finding that successful hospital-adapted E. faecium strains may
evolve from different genetic backgrounds, including those that
prevail in animal reservoirs, has consequences for the potential
flow of genes conferring resistance or virulence through the E. fae-
cium population contained in various human and nonhuman
ecological niches. Improved understanding of population struc-
ture can assist effective control by defining those parts of the pop-
ulation most associated with particular settings, such as health
care or agriculture. The finding of distinct health care and agricul-
tural populations ofE. faeciumwill also facilitate future research in
disclosing genetic differences between these populations. This will
improve our understanding of the pathophysiological processes
that have led to adaptation of the three major hospital lineages to
the hospital environment. Increased insights in genes or genetic
elements implicated in hospital adaptation may lead to the iden-
tification of novel targets for antibiotics and immunotherapy to
combat E. faecium infections.
MATERIALS AND METHODS
Bacterial isolates. MLST data from 1,749 enterococcal isolates (1,720
E. faecium and 29 E. faecalis isolates), representing in total 519 different
STs (491 in E. faecium and 28 in E. faecalis), were included in this study.
The 491 STs in E. faecium as well as the concatenated sequences of the
seven MLST genes are accessible through and can be downloaded from
the E. faeciumMLST website (http://efaecium.mlst.net/). The 29 E. faeca-
lis isolates represented all the isolates for which whole genome sequences
were available at the time of analysis (January 2011). Alleles and STs of the
E. faecalis isolates were assigned in silico using the whole genome sequence
Willems et al.
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data following the E. faecium MLST scheme. Metadata of the included
isolates are shown in Table S1 in the supplemental material.
Population genetic analysis. Population genetic analyses were per-
formed using BAPS software (30) with the second-order Markov model
and the standardMLST data input option, similarly as described in refer-
ences 31, 32, 34, and 36. The optimal number of clusters was calculated
using 10 runs of the estimation algorithm, with the prior upper bound of
the number of clusters varying in the range of 10 to 30 over the 10 repli-
cates. All estimation runs yielded an identical partition of the ST data with
7 clusters (estimated P value of 1.000). Admixture analysis was done using
100 Monte Carlo replicates for allele frequencies and by generating 100
reference genotypes to calculate P values. For reference cases, we used 10
iterations in estimation according to the guidelines of reference 50. Mo-
saicism is defined as STs composed of sequence characteristic of more
than one BAPS group. Significance of admixture or mosaicism was deter-
mined for each ST using the threshold of P values of0.05. Phylogenetic
analysis of E. faecium BAPS 2 and 3 (sub)groups was performed using
MEGA version 4 (51). A neighbor-joining (NJ) tree was constructed with
themaximumcomposite likelihoodmodel, assuming rate uniformity and
pattern homogeneity.
The presence of E. faecalis STs in the data set leads to a substantial
number of sites where molecular variation is fixed between the two spe-
cies, reducing the resolution of clustering within the E. faecium popula-
tion. We therefore performed a consecutive clustering of the E. faecium
BAPS groups 2 and 3 using only the data from each respective group. Also,
in this analysis, 10 replicate runs of the estimation algorithm were used,
with the prior upper bound of the number of clusters varying in the range
of 2 to 10. Again, the resulting estimates of the partition of STs were
strongly supported by the posterior distribution (estimated P value of
1.000). This second run finally yielded 13 BAPS clusters within E. faecium
and one cluster including all E. faecalis isolates. Although the E. faecalis
STs were all assigned to a single cluster, one cannot rule out the presence
of multiple lineages among them: the limited number of E. faecalis STs
available for this studymeans it is not possible tomake detailed inferences
about the E. faecalis population. Relationships between STs were esti-
mated by eBURST (3).
Calculation of odds ratios. ORs and 95% confidence intervals (CIs)
were calculated relative to all other BAPS groups in the database. Associ-
ations were calculated between BAPS groups and lineage and source as
ad/bc, where a is the number of isolates from hospitalized patients, farm
animal related, or other sources (surveillance isolates from nonhospital-
ized persons, isolates from pet animals, and environmental isolates), fall-
ing into a given BAPS group, b is the number of isolates falling into the
same BAPS groups but lacking the particular feature in question, and c
and d are calculated analogously to a and b, respectively, but using all
isolates in the remainder of the E. faecium database. The total number of
isolates from a source category falling into a given BAPS group, as well as
the total number of isolates from that source category, is indicated in
Table 2. The total number of isolates included in this analysis was 1,645,
because strains from unknown sources and E. faecaliswere excluded here.
To correct for any bias arising from repeated records in the MLST
database with the same genotype and from the same source, ORs and
95% confidence intervals for associations of individual STs with source
were also calculated as indicated above. This “clone correction” will mit-
igate the bias that could be introduced by multiple testing of the same
genotype due to outbreaks or so-calledmicroepidemics. The total number
of STs from a source category falling into a given BAPS group is indicated
in Table S2 in the supplementalmaterial as well as the total number of STs
from that source category. The total number of STs included in this anal-
ysis was 511, leaving out the E. faecalis STs and STs from isolates from
unknown sources. STs found in multiple source categories were counted
multiple times.
Phylogenomics analysis. Phylogenomic analysis of E. faecium was
performed using 29 previously sequenced E. faecium genomes. A set of
299 protein sequences were identified in all 29 E. faecium genomes using
BLAT software version 335 (52) out of an initial set of 649 orthologous
protein sequences selected previously (15). Protein sequences were
aligned and concatenated using Geneious Pro 4.8.4, and subsequently
phylogenetic reconstruction was inferred using the minimum evolution
method, including bootstrapping with 1,000 iterations, using MEGA 4
(51).
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